Novel Approaches to the Study of Neonatal Infections

Abstract

The pathogenesis of neonatal infection is incompletely understood. Neonatal immune immaturity and the microbial factors of virulence only partially explain the interindividual differences in the protective responses to the most common neonatal pathogens. Stratification of infants into high- and low-risk groups through epidemiological studies has been invaluable in designing preventive strategies and reducing the burden of neonatal infection. The discovery of the role of maternal antibodies (Abs) as, for instance, anti-capsular polysaccharide group B streptococcal (GBS) Abs, in protecting newborn infants against neonatal GBS sepsis, has been a milestone in the unraveling of the molecular underpinnings of susceptibility to infection in the neonatal age. Future work should aim at defining the cellular and molecular differences in the neonatal immune responses that account for individual susceptibility and resistance to common neonatal pathogens. The interplay between the genetic and immune backgrounds of the infant, changes in the infant's microbiome, maternal factors, and the pathogen's characteristics needs to be accurately described through human studies. Precise phenotyping and dissection of the clinical heterogeneity of neonatal infection should identify cohorts that can be studied through different study methodologies. Term and preterm infants should be investigated according to the most likely underlying mechanism, single-gene disorders and multifactorial predisposition, respectively. Novel technologies, including genotyping studies, exome and genome sequencing, analysis of the microbiome, and the study of the metabolome, are nowadays established and available and can be integrated to gain a better insight into the unexplained bases of individual susceptibility to neonatal infections.

Keywords

newborn infant - infection - primary immunodeficiency - phenotype - genetic - single-gene

• References

• 1 Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7 (05) 379-390
• 2 Adkins B, Chun K, Hamilton K, Nassiri M. Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J Immunol 1996; 157 (04) 1343-1349
• 3 Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271 (5256): 1726-1728
• 4 Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996; 271 (5256): 1728-1730
• 5 Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271 (5256): 1723-1726
• 6 Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008; 68 (04) 293-300
• 7 Verani JR, McGee L, Schrag SJ. ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). 2010 Guidelines for the prevention of perinatal group B streptococcal disease: Revised Guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-32
• 8 Berardi A, Rossi C, Lugli L. , et al; GBS Prevention Working Group, Emilia-Romagna. Group B streptococcus late-onset disease: 2003-2010. Pediatrics 2013; 131 (02) e361-e368
• 9 Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, Poyart C. Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol 2012; 15 (01) 44-49
• 10 Baker CJ, Carey VJ, Rench MA. , et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2014; 209 (05) 781-788
• 11 Le Doare K, Allen L, Kampmann B. , et al. Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection. Vaccine 2015; 33 (05) 621-627
• 12 Dangor Z, Kwatra G, Izu A. , et al. HIV-1 is associated with lower group B Streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis 2015; 212 (03) 453-462
• 13 Oxelius VA, Lindén V, Christensen KK, Christensen P. Deficiency of IgG subclasses in mothers of infants with group B streptococcal septicemia. Int Arch Allergy Appl Immunol 1983; 72 (03) 249-252
• 14 Brocklehurst P, Farrell B, King A. , et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365 (13) 1201-1211
• 15 Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013; 7 (07) CD000361
• 16 Alcaïs A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?. Ann N Y Acad Sci 2010; 1214: 18-33
• 17 Borghesi A, Stronati M, Fellay J. Neonatal group B Streptococcal disease in otherwise healthy infants: failure of specific neonatal immune responses. Front Immunol 2017; 8: 215
• 18 Israel L, Wang Y, Bulek K. , et al. Human adaptive immunity rescues an inborn error of innate immunity. Cell 2017; 168 (05) 789-800.e10
• 19 Kolter J, Henneke P. Codevelopment of microbiota and innate immunity and the risk for group B streptococcal disease. Front Immunol 2017; 8: 1497
• 20 Döffinger R, Helbert MR, Barcenas-Morales G. , et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004; 38 (01) e10-e14
• 21 Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis 2010; 10 (12) 875-885
• 22 Clausen ML, Agner T, Lilje B, Edslev SM, Johannesen TB, Andersen PS. Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis. JAMA Dermatol 2018
• 23 Srinivasan L, Swarr DT, Sharma M, Cotten CM, Kirpalani H. Systematic review and meta-analysis: gene association studies in neonatal sepsis. Am J Perinatol 2017; 34 (07) 684-692
• 24 Srinivasan L, Kirpalani H, Cotten CM. Elucidating the role of genomics in neonatal sepsis. Semin Perinatol 2015; 39 (08) 611-616
• 25 Srinivasan L, Page G, Kirpalani H. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 2017; 102 (05) F439-F445